Check-Cap (NASDAQ: CHEK)
$2.27
(2.3%)
$0.05
Price as of April 25, 2024, 3:59 p.m. ET
Check-Cap Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Check-Cap Company Info
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule system for colorectal cancer screening. Its patented technology, C-Scan, is a patient-friendly preparation-free test designed to detect polyps before they may transform into cancer. The company was founded by Yoav Kimchy in 2005 and is headquartered in Isfiya, Israel.
News & Analysis
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.